SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-006649
Filing Date
2019-03-07
Accepted
2019-03-07 16:12:50
Documents
1
Period of Report
2019-03-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6069
  Complete submission text file 0000899243-19-006649.txt   7400
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address CRISPR THERAPEUTICS AG 610 MAIN STREET CAMBRIDGE MA 02139
Business Address
Ho Tony W (Reporting) CIK: 0001713637 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37923 | Film No.: 19665993